Calendar Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Market Closed - Nasdaq Stockholm 11:29:41 2024-04-19 am EDT 5-day change 1st Jan Change
261 SEK +0.62% Intraday chart for Swedish Orphan Biovitrum AB +3.24% -2.25%

Chart calendar Swedish Orphan Biovitrum AB

64d50fd82b24f92f84770.9HbbegLMSVGCJ7zfLMqG19877AKhkel0mWrJoS5tve4.vROdHW-7MQjsE_GXFLvOhIxoqnqZpqpF1BKclFwy1YaOJIQ2SaN7DrVu3w~afe2e7c73468af956140005350cfaff9

Upcoming events on Swedish Orphan Biovitrum AB

2024-04-25 02:00 am Q1 2024 Earnings Release
2024-04-25 10:00 am Q1 2024 Earnings Call
2024-05-14 09:00 am Annual General Meeting
2024-07-15 Q2 2024 Earnings Release
2024-10-23 Q3 2024 Earnings Release
2025-02-04 Q4 2024 Earnings Release
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-07-21 Q2 2025 Earnings Release (Projected)
2025-10-22 Q3 2025 Earnings Release (Projected)
2026-02-04 Q4 2025 Earnings Release (Projected)

Past events on Swedish Orphan Biovitrum AB

2024-02-08 08:00 am Q4 2023 Earnings Call
2024-02-08 04:22 am Q4 2023 Earnings Release
2023-12-08 American Society of Hematology Meeting
2023-11-01 American Society of Nephrology Kidney Week Meeting
2023-10-30 08:00 am Q3 2023 Earnings Call
2023-10-30 03:37 am Q3 2023 Earnings Release
2023-09-18 09:00 am Investor Meeting - KOL
2023-08-27 Rights Issue: 1 new share @ 142 SEK for 7 existing shares
2023-08-15 04:00 am Extraordinary Shareholders Meeting
2023-07-19 09:30 am Investor Meeting - Key Opinion Leader
2023-07-18 07:00 am Q2 2023 Earnings Call
2023-07-18 04:39 am Q2 2023 Earnings Release
2023-06-28 Investor Meeting - Stiefel
2023-06-24 International Society on Thrombosis and Haemostasis Meeting
2023-05-10 09:00 am Acquisition of CTI BioPharma Corp by Swedish Orphan Biovitrum AB Call
2023-05-09 09:00 am Annual General Meeting
2023-04-27 08:00 am Q1 2023 Earnings Call
2023-04-27 02:34 am Q1 2023 Earnings Release
2023-02-08 07:00 am FY 2022 Earnings Call
2023-02-08 04:21 am FY 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
14 248
14 210
0.26%
15 261
15 155
0.7%
15 529
15 338
1.24%
18 790
18 363
2.32%
22 123
21 968
0.71%

24 129

EBITDA
Million SEK
Released
Forecast
Spread
6 121
6 302
-2.87%
6 830
6 196
10.24%
5 740
5 466
5.01%
6 758
6 072
11.3%
7 676
7 475
2.69%

8 928

EBIT
Million SEK
Released
Forecast
Spread
4 533
4 774
-5.04%
4 818
4 110
17.24%
3 733
3 539
5.47%
4 488
4 051
10.78%
4 485
4 437
1.07%

5 593

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
4 247
4 540
-6.46%
4 217
3 562
18.38%
3 295
3 108
6.03%
3 321
3 270
1.56%
2 954
3 399
-13.09%

4 432

Net income
Million SEK
Released
Forecast
Spread
3 304
3 556
-7.08%
3 245
2 743
18.31%
2 679
2 375
12.8%
2 638
2 620
0.69%
2 409
2 695
-10.6%

3 526

EPS
SEK
Released
Forecast
Spread
11,2
12,1
-6.99%
10,9
9,25
17.9%
9,03
8,01
12.75%
8,84
8,84
0.01%
7,39
8,46
-12.69%

10,3

Announcement Date13/02/2018/02/2110/02/2208/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million SEK
Released
Forecast
Spread
4 896
4 702
4.13%
4 925
4 470
10.17%
3 876
3 533
9.72%
3 999
3 905
2.41%
5 991
5 512
8.7%
5 239
5 142
1.89%
4 872
4 403
10.66%
5 168
4 628
11.66%
6 844
6 735
1.62%

5 805


5 128


6 009


7 218


6 298

EBITDA
Million SEK
Released
Forecast
Spread
2 061
1 967
4.78%
1 461
1 608
-9.17%
997
854
16.69%
1 278
1 170
9.27%
2 493
2 298
8.49%
2 159
1 768
22.11%
1 286
1 079
19.18%
1 585
1 122
41.3%
2 645
2 681
-1.34%

2 015


1 331


1 949


3 188


2 765

EBIT
Million SEK
Released
Forecast
Spread
1 525
1 457
4.7%
1 437
1 169
22.96%
423
376
12.36%
699
739
-5.42%
1 916
1 764
8.6%
1 495
1 208
23.75%
413
531
-22.27%
547
441
23.98%
1 691
1 970
-14.16%

1 114


513


1 355


2 212


1 826

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
1 423
1 359
4.69%
674
1 061
-36.48%
317
278
13.96%
564
495
13.99%
1 766
1 689
4.57%
1 325
1 032
28.33%
275
329
-16.51%
116
239
-51.51%
1 237
1 804
-31.41%

811


142


794


2 071


1 640

Net income
Million SEK
Released
Forecast
Spread
1 241
1 059
17.17%
543
909
-40.23%
258
211
22.49%
451
418
8.01%
1 386
1 303
6.36%
1 067
825
29.36%
222
244
-9.04%
94,0
192
-50.92%
1 026
1 308
-21.53%

613


113


632


1 647


1 296

EPS
SEK
Released
Forecast
Spread
4,18
3,60
15.98%
1,83
3,28
-44.21%
0,86
0,73
17.21%
1,51
1,36
10.96%
4,64
4,41
5.19%
3,56
2,79
27.8%
0,74
1,07
-30.52%
0,30
0,45
-33.96%
2,99
3,98
-24.86%

1,76


0,48


1,83


4,76


3,66

Announcement Date10/02/2228/04/2219/07/2227/10/2208/02/2327/04/2318/07/2330/10/2308/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. Calendar Swedish Orphan Biovitrum AB